about
New insights on the role of vitamin D in the progression of renal damageRegenerative medicine: does Erythropoietin have a role?Erythropoietin and the truths of science.NGAL is a precocious marker of therapeutic response.Fibrosis, regeneration and cancer: what is the link?Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD.Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis.Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study.NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared.Down with the erythropoietin. Long live the erythropoietin!Vitamin D and AnemiaApelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based AnalysisWernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case ReportErythropoiesis and chronic kidney disease-related anemia: From physiology to new therapeutic advancementsRAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitusStress-induced hashitoxicosis: case report and relative HLA serotype and genotypeComplement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion
P50
Q26829215-3A8057C3-212E-4586-A94C-5C6F1A411435Q37515923-81B3B5A6-7835-44D8-B0FD-C1AC46A292EFQ37807948-139CFD2F-1D13-4CB6-9CED-BA1F9FD6DC64Q37849805-4A03661B-C3F5-4C3F-A343-3B40F37ADA6CQ37958843-98FBB3C0-8D5A-49AD-BEA5-715337569E5EQ38080804-1612B123-4DD2-4087-B093-484E310053DDQ46799554-121FC8A4-9C4B-4FE9-BE30-CCF3592DB8F3Q47169238-3245CD1B-F10F-4D11-97CF-C3CBC98DE628Q48279308-60D5F59E-D71F-4AE9-8904-91F79DCB1ECCQ48703535-6DFB6A34-242E-4154-924E-36A3BE66704BQ50594371-A583512F-B54C-4DF7-893C-065A99F3E22EQ58912030-595A984D-7AFD-43A3-B577-B4B73A5B307EQ58912060-5B639D80-B9B0-480C-9587-49A3E3DE56C5Q58912093-D9D4E7AF-6BEA-4BEC-B4DD-DA9F48544C08Q89544553-D2FA743C-5F03-4B4A-AC23-0A0887B033F5Q90226306-8E6F0C74-43BA-434A-BF0D-6B228F512983Q90798391-DF24A70C-3CD7-41F0-8DB2-54B7FB88D7D0Q92105748-DE8299CB-9380-4AA0-907B-39329A0C1F29Q92149110-1D0A6374-11FB-461E-9784-C416C7A01B86Q94480680-0E9A33C2-23F0-4988-B921-833C241F094F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valeria Cernaro
@ast
Valeria Cernaro
@en
Valeria Cernaro
@es
Valeria Cernaro
@nl
Valeria Cernaro
@sl
type
label
Valeria Cernaro
@ast
Valeria Cernaro
@en
Valeria Cernaro
@es
Valeria Cernaro
@nl
Valeria Cernaro
@sl
prefLabel
Valeria Cernaro
@ast
Valeria Cernaro
@en
Valeria Cernaro
@es
Valeria Cernaro
@nl
Valeria Cernaro
@sl
P1053
K-8169-2016
P106
P21
P31
P3829
P496
0000-0003-4396-5032